Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Oncology
Join Editorial Board Propose a Special Issue
Print ISSN: 1019-6439 Online ISSN: 1791-2423
Journal Cover
July-2022 Volume 61 Issue 1

Full Size Image

Cover Legend PDF

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
July-2022 Volume 61 Issue 1

Full Size Image

Cover Legend PDF

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data1.pdf
    • Supplementary_Data2.pdf
Article Open Access

Receptor for activated C kinase 1 promotes cervical cancer lymph node metastasis via the glycolysis‑dependent AKT/mTOR signaling

  • Authors:
    • Lixiu Xu
    • Jinqiu Li
    • Mikrban Tursun
    • Yan Hai
    • Hatila Tursun
    • Batur Mamtimin
    • Ayshamgul Hasim
  • View Affiliations / Copyright

    Affiliations: Department of Basic Medicine, Xinjiang Medical University and Xinjiang Key Laboratory of Molecular Biology of Endemic Diseases, Urumqi, Xinjiang 830017, P.R. China, Department of Pharmacy, Xinjiang Medical University, Urumqi, Xinjiang 830017, P.R. China
    Copyright: © Xu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 83
    |
    Published online on: May 24, 2022
       https://doi.org/10.3892/ijo.2022.5373
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Cervical cancer (CC), an aggressive form of squamous cell carcinoma, is characterized by early‑stage lymph node metastasis and an extremely poor prognosis. The authors have previously demonstrated that patients with CC have aberrant glycolysis. The upregulation of receptor for activated C kinase 1 (RACK1) is associated with CC lymph node metastasis (LNM). However, its role in mediating aerobic glycolysis in CC LNM remains unclear. In the present study, 1H nuclear magnetic resonance analysis revealed a significant association between RACK1 expression and the glycolysis/gluconeogenesis pathway. Additionally, RACK1 knockdown inhibited aerobic glycolysis and lymphangiogenesis in vitro and suppressed CC LNM in vivo. Furthermore, protein kinase B (AKT)/mammalian target of rapamycin (mTOR) signaling was identified as a critical RACK1‑regulated pathway that increased lymphangiogenesis in CC. Co‑immunoprecipitation, immunofluorescence and western blot analysis revealed that RACK1 activated AKT/mTOR signaling by interacting with insulin‑like growth factor 1 receptor (IGF1R). POU class 2 homeobox 2 (POU2F2) bound to the RACK1 promoter and regulated its transcription, thereby functionally contributing to glycolysis and lymphangiogenesis in CC. Of note, the administration of 2‑deoxy‑D‑glucose, which attenuates glycolysis, inhibited RACK1‑induced lymphangiogenesis in CC. The correlations between RACK1, IGF1R, POU2F2 and hexokinase 2 were further confirmed in CC tissues. Thus, RACK1 plays a crucial role in CC tumor LNM by regulating glycolysis via IGF1R/AKT/mTOR signaling. Thus, the targeting of the POU2F2/RACK1/IGF1R/AKT/mTOR signaling pathway may provide a novel treatment strategy for CC.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

View References

1 

Kagabu M, Yoshino N, Saito T, Miura Y, Takeshita R, Murakami K, Kawamura H, Baba T and Sugiyama T: The efficacy of a third-generation oncolytic herpes simplex viral therapy for an HPV-related uterine cervical cancer model. Int J Clin Oncol. 26:591–597. 2021. View Article : Google Scholar

2 

Husaiyin S, Jiao Z, Yimamu K, Maisaidi R, Han L and Niyazi M: Thinprep cytology combined with hpv detection in the diagnosis of cervical lesions in 1622 patients. PLoS One. 16:e02609152021. View Article : Google Scholar

3 

Yang H, Kuo YH, Smith ZI and Spangler J: Targeting cancer metastasis with antibody therapeutics. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 13. pp. e16982021, View Article : Google Scholar

4 

Federico C, Sun J, Muz B, Alhallak K, Cosper PF, Muhammad N, Jeske A, Hinger A, Markovina S, Grigsby P, et al: Localized delivery of cisplatin to cervical cancer improves its therapeutic efficacy and minimizes its side effect profile. Int J Radiat Oncol Biol Phys. 109:1483–1494. 2021. View Article : Google Scholar

5 

Swartz MA and Lund AW: Lymphatic and interstitial flow in the tumour microenvironment: Linking mechanobiology with immunity. Nat Rev Cancer. 12:210–219. 2012. View Article : Google Scholar

6 

Fagiani E, Lorentz P, Bill R, Pavotbawan K, Kopfstein L and Christofori G: Vegf receptor-2-specific signaling mediated by vegf-e induces hemangioma-like lesions in normal and in malignant tissue. Angiogenesis. 19:339–358. 2016. View Article : Google Scholar

7 

Liu D, Zeinolabediny Y, Caccuri F, Ferris G, Fang WH, Weston R, Krupinski J, Colombo L, Salmona M, Corpas R, et al: P17 from hiv induces brain endothelial cell angiogenesis through egfr-1-mediated cell signalling activation. Lab Invest. 99:180–190. 2019. View Article : Google Scholar

8 

Park MK, Zhang L, Min KW, Cho JH, Yeh CC, Moon H, Hormaechea-Agulla D, Mun H, Ko S, Lee JW, et al: Neat1 is essential for metabolic changes that promote breast cancer growth and metastasis. Cell Metab. 33:2380–2397. 2021. View Article : Google Scholar

9 

Vaupel P, Schmidberger H and Mayer A: The warburg effect: Essential part of metabolic reprogramming and central contributor to cancer progression. Int J Radiat Biol. 95:912–919. 2019. View Article : Google Scholar

10 

Luo P, Zhang C, Liao F, Chen L, Liu Z, Long L, Jiang Z, Wang Y, Wang Z, Liu Z, et al: Transcriptional positive cofactor 4 promotes breast cancer proliferation and metastasis through c-myc mediated warburg effect. Cell Commun Signal. 17:362019. View Article : Google Scholar

11 

Yang J, Ren B, Yang G, Wang H, Chen G, You L, Zhang T and Zhao Y: The enhancement of glycolysis regulates pancreatic cancer metastasis. Cell Mol Life Sci. 77:305–321. 2020. View Article : Google Scholar

12 

Hasim A, Ali M, Mamtimin B, Ma JQ, Li QZ and Abudula A: Metabonomic signature analysis of cervical carcinoma and precancerous lesions in women by (1)H NMR spectroscopy. Exp Ther Med. 3:945–951. 2012. View Article : Google Scholar

13 

Wu J, Meng J, Du Y, Huang Y, Jin Y, Zhang J, Wang B, Zhang Y, Sun M and Tang J: Rack1 promotes the proliferation, migration and invasion capacity of mouse hepatocellular carcinoma cell line in vitro probably by pi3k/rac1 signaling pathway. Biomed Pharmacother. 67:313–319. 2013. View Article : Google Scholar

14 

Wu H, Song S, Yan A, Guo X, Chang L, Xu L, Hu L, Kuang M, Liu B, He D, et al: Rack1 promotes the invasive activities and lymph node metastasis of cervical cancer via galectin-1. Cancer Lett. 469:287–300. 2020. View Article : Google Scholar

15 

Tokunaga H, Shimada M, Ishikawa M and Yaegashi N: TNM classification of gynaecological malignant tumours, eighth edition: Changes between the seventh and eighth editions. Jpn J Clin Oncol. 49:311–320. 2019. View Article : Google Scholar

16 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar

17 

Liu D, Li C, Trojanowicz B, Li X, Shi D, Zhan C, Wang Z and Chen L: Cd97 promotion of gastric carcinoma lymphatic metastasis is exosome dependent. Gastric Cancer. 19:754–766. 2016. View Article : Google Scholar

18 

Cui B, Chen J, Luo M, Liu YY, Chen HL, Lü D, Wang LW, Kang YZ, Feng Y, Huang LB and Zhang P: PKD3 promotes metastasis and growth of oral squamous cell carcinoma through positive feedback regulation with PD-L1 and activation of ERK-STAT1/3-EMT signalling. Int J Oral Sci. 13:82021. View Article : Google Scholar

19 

Bower AJ, Li J, Chaney EJ, Marjanovic M, Spillman DR Jr and Boppart SA: High-speed imaging of transient metabolic dynamics using two-photon fluorescence lifetime imaging microscopy. Optica. 5:1290–1296. 2018. View Article : Google Scholar

20 

Li HM, Yang JG, Liu ZJ, Wang WM, Yu ZL, Ren JG, Chen G, Zhang W and Jia J: Blockage of glycolysis by targeting pfkfb3 suppresses tumor growth and metastasis in head and neck squamous cell carcinoma. J Exp Clin Cancer Res. 36:72017. View Article : Google Scholar

21 

Wan J, Liu Y, Long F, Tian J and Zhang C: Circpvt1 promotes osteosarcoma glycolysis and metastasis by sponging mir-423-5p to activate wnt5a/ror2 signaling. Cancer Sci. 112:1707–1722. 2021. View Article : Google Scholar

22 

Lenz G, Hamilton A, Geng S, Hong T, Kalkum M, Momand J, Kane SE and Huss JM: T-darpp activates igf-1r signaling to regulate glucose metabolism in trastuzumab-resistant breast cancer cells. Clin Cancer Res. 24:1216–1226. 2018. View Article : Google Scholar

23 

Hermanto U, Zong CS, Li WQ and Wang LH: RACK1, an insulin-like growth factor I (IGF-I) receptor-interacting protein, modulates IGF-I-dependent integrin signaling and promotes cell spreading and contact with extracellular matrix. Mol Cell Biol. 22:2345–2365. 2002. View Article : Google Scholar

24 

Zhang W, Zong CS, Hermanto U, Lopez-Bergami P, Ronai Z and Wang LH: Rack1 recruits stat3 specifically to insulin and insulin-like growth factor 1 receptors for activation, which is important for regulating anchorage-independent growth. Mol Cell Biol. 26:413–424. 2006. View Article : Google Scholar

25 

Lin T, Yang Y, Ye X, Yao J and Zhou H: Low expression of mir-99b promotes progression of clear cell renal cell carcinoma by up-regulating igf1r/akt/mtor signaling. Int J Clin Exp Pathol. 13:3083–3091. 2020.

26 

Ellis BC, Graham LD and Molloy PL: Crnde, a long non-coding rna responsive to insulin/igf signaling, regulates genes involved in central metabolism. Biochim Biophys Acta. 1843:372–386. 2014. View Article : Google Scholar

27 

Sun T, Liu Z and Yang Q: The role of ubiquitination and deubiquitination in cancer metabolism. Mol Cancer. 19:1462020. View Article : Google Scholar

28 

Zhou L and Xu XL: Long non-coding rna arap1-as1 facilitates the progression of cervical cancer by regulating mir-149-3p and pou2f2. Pathobiology. 88:301–312. 2021. View Article : Google Scholar

29 

Yang R, Wang M, Zhang G, Li Y, Wang L and Cui H: Pou2f2 regulates glycolytic reprogramming and glioblastoma progression via pdpk1-dependent activation of pi3k/akt/mtor pathway. Cell Death Dis. 12:4332021. View Article : Google Scholar

30 

Guler OC, Torun N, Yildirim BA and Onal C: Pretreatment metabolic tumour volume and total lesion glycolysis are not independent prognosticators for locally advanced cervical cancer patients treated with chemoradiotherapy. Br J Radiol. 91:201705522018. View Article : Google Scholar

31 

Cegla P, Burchardt E, Roszak A, Czepczynski R, Kubiak A and Cholewinski W: Influence of biological parameters assessed in [18f]fdg pet/ct on overall survival in cervical cancer patients. Clin Nucl Med. 44:860–863. 2019. View Article : Google Scholar

32 

Osaku D, Komatsu H, Okawa M, Iida Y, Sato S, Oishi T and Harada T: Re-classification of uterine cervical cancer cases treated with radical hysterectomy based on the 2018 figo staging system. Taiwan J Obstet Gynecol. 60:1054–1058. 2021. View Article : Google Scholar

33 

Duan F, Wu H, Jia D, Wu W, Ren S, Wang L, Song S, Guo X, Liu F, Ruan Y and Gu J: O-glcnacylation of rack1 promotes hepatocellular carcinogenesis. J Hepatol. 68:1191–1202. 2018. View Article : Google Scholar

34 

Han H, Wang D, Yang M and Wang S: High expression of rack1 is associated with poor prognosis in patients with pancreatic ductal adenocarcinoma. Oncol Lett. 15:2073–2078. 2018.

35 

Wang J and Chen S: Rack1 promotes mir-302b/c/d-3p expression and inhibits ccno expression to induce cell apoptosis in cervical squamous cell carcinoma. Cancer Cell Int. 20:3852020. View Article : Google Scholar

36 

Zhu X, Chen L, Liu L and Niu X: EMT-mediated acquired EGFR-TKI resistance in NSCLC: Mechanisms and strategies. Front Oncol. 9:10442019. View Article : Google Scholar

37 

Mahmood MQ, Ward C, Muller HK, Sohal SS and Walters EH: Epithelial mesenchymal transition (EMT) and non-small cell lung cancer (NSCLC): A mutual association with airway disease. Med Oncol. 34:452017. View Article : Google Scholar

38 

Torresano L, Nuevo-Tapioles C, Santacatterina F and Cuezva JM: Metabolic reprogramming and disease progression in cancer patients. Biochim Biophys Acta Mol Basis Dis. 1866:1657212020. View Article : Google Scholar

39 

Li S, Zhu K, Liu L, Gu J, Niu H and Guo J: Lncarsr sponges mir-34a-5p to promote colorectal cancer invasion and metastasis via hexokinase-1-mediated glycolysis. Cancer Sci. 111:3938–3952. 2020. View Article : Google Scholar

40 

Liang J, Yang Y, Bai L, Li F and Li E: Drp1 upregulation promotes pancreatic cancer growth and metastasis through increased aerobic glycolysis. J Gastroenterol Hepatol. 35:885–895. 2020. View Article : Google Scholar

41 

Gong X, Tang H and Yang K: Per1 suppresses glycolysis and cell proliferation in oral squamous cell carcinoma via the per1/rack1/pi3k signaling complex. Cell Death Dis. 12:2762021. View Article : Google Scholar

42 

Baserga R: The Igf-I receptor in cancer research. Exp Cell Res. 253:1–6. 1999. View Article : Google Scholar

43 

Han L: Mir-99a inhibits proliferation and migration of cervical cancer cells by targeting igf1r. J BUON. 26:1782–1788. 2021.

44 

Sin STK, Li Y, Liu M, Ma S and Guan XY: Trop-2 exhibits tumor suppressive functions in cervical cancer by dual inhibition of igf-1r and alk signaling. Gynecol Oncol. 152:185–193. 2019. View Article : Google Scholar

45 

Kiely PA, Sant A and O'Connor R: Rack1 is an insulin-like growth factor 1 (igf-1) receptor-interacting protein that can regulate igf-1-mediated akt activation and protection from cell death. J Biol Chem. 277:22581–22589. 2002. View Article : Google Scholar

46 

Caromile LA, Dortche K, Rahman MM, Grant CL, Stoddard C, Ferrer FA and Shapiro LH: Psma redirects cell survival signaling from the mapk to the pi3k-akt pathways to promote the progression of prostate cancer. Sci Signal. 10:eaag33262017. View Article : Google Scholar

47 

He X, Wang J, Messing EM and Wu G: Regulation of receptor for activated c kinase 1 protein by the von hippellindau tumor suppressor in igf-i-induced renal carcinoma cell invasiveness. Oncogene. 30:535–547. 2011. View Article : Google Scholar

48 

Wu Q, Ma J, Wei J, Meng W, Wang Y and Shi M: Foxd1-as1 regulates foxd1 translation and promotes gastric cancer progression and chemoresistance by activating the pi3k/akt/mtor pathway. Mol Oncol. 15:299–316. 2021. View Article : Google Scholar

49 

Li ZQ, Qu M, Wan HX, Wang H, Deng Q and Zhang Y: Foxk1 promotes malignant progression of breast cancer by activating PI3K/AKT/MTOR signaling pathway. Eur Rev Med Pharmacol Sci. 23:9978–9987. 2019.

50 

Zheng Y, Wu C, Yang J, Zhao Y, Jia H, Xue M, Xu D, Yang F, Fu D, Wang C, et al: Insulin-like growth factor 1-induced enolase 2 deacetylation by hdac3 promotes metastasis of pancreatic cancer. Signal Transduct Target Ther. 5:532020. View Article : Google Scholar

51 

Wang SM, Tie J, Wang WL, Hu SJ, Yin JP, Yi XF, Tian ZH, Zhang XY, Li MB, Li ZS, et al: Pou2f2-oriented network promotes human gastric cancer metastasis. Gut. 65:117–1438. 2016. View Article : Google Scholar

52 

Bentrari F, Chantôme A, Knights A, Jeannin JF and Pance A: Oct-2 forms a complex with oct-1 on the inos promoter and represses transcription by interfering with recruitment of rna polii by oct-1. Nucleic Acids Res. 43:9757–9765. 2015.

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Xu L, Li J, Tursun M, Hai Y, Tursun H, Mamtimin B and Hasim A: Receptor for activated C kinase 1 promotes cervical cancer lymph node metastasis via the glycolysis‑dependent AKT/mTOR signaling. Int J Oncol 61: 83, 2022.
APA
Xu, L., Li, J., Tursun, M., Hai, Y., Tursun, H., Mamtimin, B., & Hasim, A. (2022). Receptor for activated C kinase 1 promotes cervical cancer lymph node metastasis via the glycolysis‑dependent AKT/mTOR signaling. International Journal of Oncology, 61, 83. https://doi.org/10.3892/ijo.2022.5373
MLA
Xu, L., Li, J., Tursun, M., Hai, Y., Tursun, H., Mamtimin, B., Hasim, A."Receptor for activated C kinase 1 promotes cervical cancer lymph node metastasis via the glycolysis‑dependent AKT/mTOR signaling". International Journal of Oncology 61.1 (2022): 83.
Chicago
Xu, L., Li, J., Tursun, M., Hai, Y., Tursun, H., Mamtimin, B., Hasim, A."Receptor for activated C kinase 1 promotes cervical cancer lymph node metastasis via the glycolysis‑dependent AKT/mTOR signaling". International Journal of Oncology 61, no. 1 (2022): 83. https://doi.org/10.3892/ijo.2022.5373
Copy and paste a formatted citation
x
Spandidos Publications style
Xu L, Li J, Tursun M, Hai Y, Tursun H, Mamtimin B and Hasim A: Receptor for activated C kinase 1 promotes cervical cancer lymph node metastasis via the glycolysis‑dependent AKT/mTOR signaling. Int J Oncol 61: 83, 2022.
APA
Xu, L., Li, J., Tursun, M., Hai, Y., Tursun, H., Mamtimin, B., & Hasim, A. (2022). Receptor for activated C kinase 1 promotes cervical cancer lymph node metastasis via the glycolysis‑dependent AKT/mTOR signaling. International Journal of Oncology, 61, 83. https://doi.org/10.3892/ijo.2022.5373
MLA
Xu, L., Li, J., Tursun, M., Hai, Y., Tursun, H., Mamtimin, B., Hasim, A."Receptor for activated C kinase 1 promotes cervical cancer lymph node metastasis via the glycolysis‑dependent AKT/mTOR signaling". International Journal of Oncology 61.1 (2022): 83.
Chicago
Xu, L., Li, J., Tursun, M., Hai, Y., Tursun, H., Mamtimin, B., Hasim, A."Receptor for activated C kinase 1 promotes cervical cancer lymph node metastasis via the glycolysis‑dependent AKT/mTOR signaling". International Journal of Oncology 61, no. 1 (2022): 83. https://doi.org/10.3892/ijo.2022.5373
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team